Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine

Title
Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine
Authors
Keywords
Precision medicine, Targeted cancer therapy, Superantigen, ADEPT, Checkpoint inhibitors, PROTAC, Antibody drug conjugate, Cancer immunotherapy
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 125, Issue -, Pages 110009
Publisher
Elsevier BV
Online
2020-02-25
DOI
10.1016/j.biopha.2020.110009

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started